#clinicalstudy — Public Fediverse posts

Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses

Sanofi Winthrop Industrie Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP …
#France #FR #Europe #EU #Sanofi #AmericanAcademyofNeurology #clinicalstudy #cognitiveimpairment #EuropeanMedicinesAgency #liverenzymeelevations #phase3studies #progressivemultiplesclerosis #tolebrutinib
https://www.europesays.com/france/18870/

https://www.europesays.com/ie/472823/ Your smartwatch can predict if you’re about to faint, research finds #ChungAngUniversity #ClinicalStudy #Éire #HeartRateVariability #IE #Ireland #patients #ProfessorJunhwanCho #Samsung #smartwatch #Technology #VasovagalSyncope

https://www.europesays.com/ch/46706/ Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 #Allschwil #AntibacterialProducts #AntimicrobialResistance #BacterialInfections #Basel #BasileaPharmaceutica #BiopharmaceuticalCompany #ClinicalDevelopment #ClinicalStudy #development #FungalInfections #NovelAntibiotic #ProductDevelopment #ResearchAndDevelopment #WorldHealthOrganization

Blood test boosts Alzheimer's diagnosis accuracy to 94.5%, clinical study shows

https://medicalxpress.com/news/2026-02-blood-boosts-alzheimer-diagnosis-accuracy.html

#HackerNews #BloodTest #MedicalResearch #ClinicalStudy #HealthTech

🦠💊 An international research team has developed a new treatment approach for severe COVID-19, potentially enabling faster recovery and reduced mortality. Results from the Phase II study show that the FasL inhibitor Asunercept allows recovery in an average of 8 days—compared to 13 days in the control group. 📊🔬

Read more ➡️ https://uni.koeln/V3TPT

📰 https://www.sciencedirect.com/science/article/pii/S2589537024004589?via%3Dihub

#UniKöln #UniCologne #COVID19 #Research #Health #Medicine #Therapy #ClinicalStudy #Recovery #Immunology

https://www.europesays.com/uk/521108/ Elevara Medicines Raises $70 Million Series A to Advance ##CDK4/6 ##clinicalstudy ##companylaunch ##rheumatoidarthritis ##SeriesA #Biotech #ElevaraMedicinesLimited #Health #Healthcare #Therapeutics #UK #UnitedKingdom #VentureCapital